Skip to main content
All lobbying filings

Cencora, Inc.

Cencora, Inc. filed a Q1 report for Cencora, Inc. on April 21, 2025.

Lobbying for Cencora, Inc.

As filed: CENCORA, INC. for CENCORA, INC.

All filings by Cencora, Inc. · Everything Cencora, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$450,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Medicare/Medicaid

The Equitable Community Access to Pharmacist Services Act Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act Seniors Access to Critical Medicines Act (H.R. 2484) Protecting Patient Access to Cancer and Complex Therapies Act Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

Pharmacy

Pharmacy and Medically Underserved Area Enhancement Act Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act Seniors Access to Critical Medications Act (H.R. 2484)

Health Issues

Strategic National Stockpile. Essential Medicines Strategic Stockpile Act Prescription Information Modernization Act Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization FY2025 National Defense Authorization Act (NDAA) Seniors Access to Critical Medications Act (H.R. 2484) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA

Taxation/Internal Revenue Code

Tax Cuts and Jobs Act of 2017. LIFO accounting method Global Intangible Low-taxed Income (GILTI) Fiscal Year 2025 Budget Resolution (S. CON. RES. 7/ H.Con.Res.14)

 Bills named in this filing 3
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • S. Con. Res. 7
    An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem